Skip to main content
Premium Trial:

Request an Annual Quote

European Research Commission Identifies Genomics as Key Budget Priority

NEW YORK, Feb 23 – The European Commission has proposed a new research and innovation budget for the European Union that highlights genomics as a key priority in the next four years, the EC said Thursday.

The budget of 17.5 billion euros ($15.8 billion) for research comprises part of an initiative to create a European Research Area.

"In this new program, I am putting forward proposals to help businesses develop the key technologies for the future, and for our universities and research centers to work closer together to strengthen Europe's science base,” said Commissioner Philippe Busquin in a statement.

Genomics is one of seven research priorities Busquin highlighted in his proposal. The genomics research funded by this budget will aim to harness the power of the decoded genome to help tackle major diseases and build up the European biotechnology industry, according to the statement.

The new program also works on technology transfer, providing help with intellectual property rights, accessing capital, and developing transnational partnerships. 

The European Council and the European Parliament will make the final decision on whether to approve the Commission’s budget.

The proposal did not specify what proportion of the budget will be apportioned for genomics.

 

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.